Search Results

Considerations for the Management of Oncology Patients During the COVID-19 Pandemic.

• Authors : Huang, Julie; Rohatgi, Abhinav; Schneider, Jeffrey

• Source: Oncology (08909091); Oct2020, Vol. 34 Issue 10, p432-441, 10p

Record details

New chemotherapeutic approaches in superficial bladder cancer.

• Authors : Katz, Matthew; Andriole, Gerald L.

Subjects: THERAPEUTICS; CANCER patients; MITOMYCIN C

• Source: Urology Times. 9/1/2009, Vol. 37 Issue 10, ps9-s14. 6p.

Record details

Treating BCG-resistant superficial bladder cancer: evidence based options.

• Authors : Chang SS (AUTHOR); Crawford ED (AUTHOR); Pruthi R (CONTRIBUTOR)

• Source: Urology Times. 5/15/2008 Treating BCG-Resistant, Vol. 36, p1-8. 8p.

Record details

Treating BCG-Resistant Superficial Bladder Cancer: Evidence-Based Options.

Subjects: RESEARCH; BLADDER cancer; ALTERNATIVE treatment for cancer

• Source: Urology Times. 5/15/2008 Treating BCG-Resistant, Vol. 36, p3-6. 4p.

Record details

Treathin BCG-Resistant Superficial Bladder Cancer: Evidence-Based Options.

Subjects: BCG vaccines; BLADDER cancer; CANCER treatment

• Source: Urology Times. 5/15/2008, Vol. 36 Issue 6, following p34-34. 4p.

Record details

New Targets for Triple-Negative Breast Cancer.

• Authors : HEROLD, CHRISTINA I.; ANDERS, CAREY K.

• Source: Oncology (08909091); Sep2013, Vol. 27 Issue 9, p846-854, 9p

Record details

Clinical advancements in treating breast cancer.

• Authors : Stacy, Tina

Subjects: BREAST cancer; CANCER chemotherapy; BIOLOGICALS

• Source: Drug Topics; 9/27/2004, Vol. 148 Issue 18, p38-47, 10p, 3 Charts

Record details

Resealed Erythrocytes: A Review.

• Authors : Gothoskar, A.V.

Subjects: ERYTHROCYTES; DRUG delivery systems; OSMOSIS

• Source: Pharmaceutical Technology; Mar2004, Vol. 28 Issue 3, p140-154, 8p, 1 Color Photograph, 1 Chart

Record details

Business to Business.

Subjects: PHARMACEUTICAL industryAVENTIS SA; SCYNEXIS Europe Ltd.; GENECARE Research Institute Co. Ltd.

• Source: BioPharm International; Jan2004, Vol. 17 Issue 1, p14-14, 2/5p

Record details

Bayer Consolidates Biotech Activities.

Subjects: BUSINESS failures; BIOTECHNOLOGY researchKYOTO (Japan); JAPANBAYER AG

• Source: BioPharm International; Jan2004, Vol. 17 Issue 1, p14-14, 3/5p

Record details